Background Pulmonary fibrosis (PF) is a shared characteristic of chronic interstitial lung
diseases of mixed aetiology. Previous studies on PF highlight a pathogenic role for common …

Background Idiopathic pulmonary fibrosis (IPF) is increasingly recognized as a chronic,
progressive and fatal lung disease with an unknown etiology. Current studies focus on …

Background Although genome-wide association studies have identified many genomic
regions associated with idiopathic pulmonary fibrosis (IPF), the causal genes and functions …

Background Idiopathic pulmonary fibrosis (IPF) is a rare and devastating fibrotic lung
disorder with unknown etiology. Although it is believed that genetic component is an …

Idiopathic pulmonary fibrosis (IPF) is a rare, incurable disease of unknown cause
characterised by progressive scarring of the lungs. The prognosis of IPF is poor with a …

Background: Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disorder of unknown cause,
affecting about three million people worldwide. Being a multifactorial disease, complex …

Rationale: Idiopathic pulmonary fibrosis (IPF) is a rare, irreversible, and progressive disease
of the lungs. Common genetic variants, in addition to nongenetic factors, have been …

Background Considerable clinical heterogeneity in idiopathic pulmonary fibrosis (IPF)
suggests the existence of multiple disease endotypes. Identifying these endotypes would …

Rationale and Objectives: Up to 20% of idiopathic interstitial lung disease is familial, referred
to as familial pulmonary fibrosis (FPF). An integrated analysis of FPF genetic risk was …

Both common and rare variants contribute to the genetic architecture of pulmonary fibrosis.
Genome-wide association studies have identified common variants, or those with a minor …